CLC and IFNAR1 are differentially expressed and a global immunity score is distinct between early- and late-onset colorectal cancer
Trude H. Ågesen(Oslo University Hospital), Rolf I. Skotheim(Oslo University Hospital), Marianne Berg(Oslo University Hospital), Arild Nesbakken(Oslo University Hospital), Espen Thiis‐Evensen(Oslo University Hospital), Torunn Fetveit(Sørlandet Hospital Arendal), Tom Mala(Oslo University Hospital), Guro E. Lind(Oslo University Hospital), Arne Bakka(Akershus University Hospital), Hans J. Hauss(Sørlandet Sykehus), Eivind Hovig(Oslo University Hospital), Trevor Clancy(Inholland University of Applied Sciences), Ragnhild A. Lothe(Oslo University Hospital), Morten H. Vatn(Oslo University Hospital), J. M. Nesland(Oslo University Hospital), Lina Cekaite(Oslo University Hospital)
Cited by 51
Related Papers
Epigenetic and genetic features of 24 colon cancer cell lines
|Oncogenesis|2013|900
A comprehensive assessment of somatic mutation detection in cancer using whole-genome sequencing
|Nature Communications|2015|337
Complete Remission with Reduction of High-Risk Clones following Haploidentical NK-Cell Therapy against MDS and AML
|Clinical Cancer Research|2018|195
Regulators of cyclin-dependent kinases are crucial for maintaining genome integrity in S phase
|The Journal of Cell Biology|2010|165
Remodeling of secretory lysosomes during education tunes functional potential in NK cells
|Nature Communications|2019|129